Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Practical Procedures & Aesthetic Dentistry : PPAD
|
November 17, 2004
Treatment selection for anterior endodontically involved teeth
Robert Rifkin, Ed McLaren
Journal of the California Dental Association
|
November 29, 2002
Macroesthetics: facial and dentofacial analysis
Edward A McLaren, Robert Rifkin
Clinical Therapeutics
|
April 30, 2019
Daratumumab Split First Versus Single Dosing Schedule Among Patients With Multiple Myeloma Treated in a US Community Oncology Setting: A Retrospective Observational Study
Robert Rifkin, David Singer, Kathleen M Aguilar, et al.
BMC Neurology
|
August 10, 2013
Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis
Harleen Saini, Robert Rifkin, Michael Gorelik, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 1, 2010
Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma
Robert Rifkin, Gary Spitzer, Gregory Orloff, et al.
American Journal of Hematology
|
February 19, 2017
A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma
James Berenson, Robert Manges, Suprith Badarinath, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 18, 2016
A Role for the GIRK3 Subunit in Methamphetamine-Induced Attenuation of GABAB Receptor-Activated GIRK Currents in VTA Dopamine Neurons
Michaelanne B Munoz, Claire L Padgett, Robert Rifkin, et al.
Clinical Therapeutics
|
February 19, 2019
Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma
Sikander Ailawadhi, Maral DerSarkissian, Mei Sheng Duh, et al.
Cell Transplantation
|
April 18, 2012
Noninvasive monitoring of immunosuppressive drug efficacy to prevent rejection of intracerebral glial precursor allografts
Michael Gorelik, Miroslaw Janowski, Chulani Galpoththawela, et al.
Frontiers in Oncology
|
August 14, 2025
A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma
Alfred L Garfall, Rahul Banerjee, Laurent Frenzel, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Practical Procedures & Aesthetic Dentistry : PPAD
|
November 17, 2004
Treatment selection for anterior endodontically involved teeth
Robert Rifkin, Ed McLaren
Journal of the California Dental Association
|
November 29, 2002
Macroesthetics: facial and dentofacial analysis
Edward A McLaren, Robert Rifkin
Clinical Therapeutics
|
April 30, 2019
Daratumumab Split First Versus Single Dosing Schedule Among Patients With Multiple Myeloma Treated in a US Community Oncology Setting: A Retrospective Observational Study
Robert Rifkin, David Singer, Kathleen M Aguilar, et al.
BMC Neurology
|
August 10, 2013
Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis
Harleen Saini, Robert Rifkin, Michael Gorelik, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 1, 2010
Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma
Robert Rifkin, Gary Spitzer, Gregory Orloff, et al.
American Journal of Hematology
|
February 19, 2017
A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma
James Berenson, Robert Manges, Suprith Badarinath, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 18, 2016
A Role for the GIRK3 Subunit in Methamphetamine-Induced Attenuation of GABAB Receptor-Activated GIRK Currents in VTA Dopamine Neurons
Michaelanne B Munoz, Claire L Padgett, Robert Rifkin, et al.
Clinical Therapeutics
|
February 19, 2019
Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma
Sikander Ailawadhi, Maral DerSarkissian, Mei Sheng Duh, et al.
Cell Transplantation
|
April 18, 2012
Noninvasive monitoring of immunosuppressive drug efficacy to prevent rejection of intracerebral glial precursor allografts
Michael Gorelik, Miroslaw Janowski, Chulani Galpoththawela, et al.
Frontiers in Oncology
|
August 14, 2025
A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma
Alfred L Garfall, Rahul Banerjee, Laurent Frenzel, et al.
Page
of 3